LI
GTHX

Leap Investments’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Leap Investments’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-24,800
Closed -$565K – 621
2019
Q3 		$565K Buy
+24,800
New +$782K 0.28% 118

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Leap Investments's GTHX Position: Q4 2019 in Review

Leap Investments sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2019, closing a stake of 24,800 shares — an estimated $565K sold.

Leap Investments first reported a position in GTHX in Q3 2019 and held it in 1 quarter. The position peaked at $565K in Q3 2019. 98 funds tracked by Wall St. Rank hold GTHX as of Q4 2019.

  • Leap Investments reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Leap Investments sold 24,800 G1 Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $565K.
  • Leap Investments first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • Leap Investments's G1 Therapeutics, Inc. Common Stock position peaked at $565K in Q3 2019.
  • 98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Leap Investments's 13F filing for Q4 2019, filed 14 Feb 2020.